Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
My research focuses on urologic oncology - molecular mechanisms, markers, early detection, natural history, treatment, translational and outcomes research. Specially, I´ve been working on the discovery, testing, and validation of molecular markers associated with the biological and clinical behavior of prostate and urothelial cancers. My laboratory research focuses on integrative genomics and epigenomics of urothelial carcinoma with the goal of designing personalized therapeutic strategies.
Pathology of the upper urinary tract tumours: Histologic subtypes, genetics, biomarker testing.
Risk factors for incidental prostate cancer following surgery for benign prostatic enlargement: A systematic review and meta-analysis.
Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274.
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 Update
TP53 Deficiency in the Natural History of Prostate Cancer
Total hospital cost of robot-assisted approach in major urological cancer surgeries
Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality.
Long-term Oncological Outcomes for Patients with Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin (BCG): A Comparative Analysis of Adequate Versus Inadequate BCG Treatment
Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis.
A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer.
Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis.
Local salvage therapies in patients with radio-recurrent prostate cancer following external beam radiotherapy: a systematic review and meta-analysis.
A Systematic Review and Meta-Analysis of Penis Length and Circumference According to WHO Regions: Who has the Biggest One?
Prognostic factors of PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis
Disparities in tissue-based biomarker testing among US Medicare beneficiaries with prostate cancer.
Academia Europaea’s guidelines for the visualization of clinical outcomes
Impact of Prostate Cancer Treatment on Quality of Life of LGBTQ+ Patients: A Systematic Review.
Trend and Cancer-Specific Prevalence of Kidney Stones Among US Cancer Survivors, 2007-2020.
Publisher Correction: Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis.
The Role of Morcellation in En Bloc Resection of Large Bladder Tumors.
Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma
Magnetic Resonance Imaging in Prostate Cancer Screening
The Financial Burden of Localized and Metastatic Bladder Cancer
PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer
Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Prostate Biopsy: A Systematic Review and Meta-analysis of Prospective Studies
The Role of Mitomycin C in Intermediate-risk Non–muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis
Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group Collaboration
Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data